Complete resolution of erythrodermic psoriasis in an HIV and HCV patient unresponsive to antipsoriatic treatments after highly active antiretroviral therapy (ritonavir, atazanavir, emtricitabine, tenofovir)

Dermatology

Volumn 225, Issue 4, 2013, Pages 333-337

  Chiricozzi, Andrea ^a,b   Saraceno, Rosita ^a   Cannizzaro, Maria Vittoria ^a   Nisticò, Steven P ^a   Chimenti, Sergio ^a   Giunta, Alessandro ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Anti tumor necrosis factor agent; Hepatitis C virus; Highly active antiretroviral therapy; Human immunodeficiency virus; Psoriasis

Indexed keywords

ANTIPSORIASIS AGENT; ATAZANAVIR; CYCLOSPORIN; EMTRICITABINE; ETRETIN; METHYLPREDNISOLONE; RITONAVIR; TENOFOVIR;

ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; ERYTHRODERMIC PSORIASIS; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; MALE; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; VIRUS LOAD;

ADENINE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEOXYCYTIDINE; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; OLIGOPEPTIDES; ORGANOPHOSPHONATES; PSORIASIS; PYRIDINES; RITONAVIR; TREATMENT OUTCOME;

EID: 84875214573     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000345762     Document Type: Review

References (34)

1. Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B: European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23: 1-70.
2. Morar N, Willis-Owen SA, Maurer T, Bunker CB: HIV-associated psoriasis: pathogenesis, clinical features, and management. Lancet Infect Dis 2010; 10: 470-478.
3. Duvic M, Johnson TM, Rapini RP, Freese T, Brewton G, Rios A: Acquired immunodeficiency syndrome-associated psoriasis and reactive arthritis. Arch Dermatol 1987; 123: 1622-1632.
4. Colebunders R, Blot K, Mertens V, Dockx P: Psoriasis regression in terminal AIDS. Lancet 1992; 339: 1110.
5. Reveille JD, Conant MA, Duvic M: Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and reactive arthritis: a disease continuum? Arthritis Rheum 1990; 33: 1574-1578.
6. Montazeri A, Kanitakis J, Bazex J: Psoriasis and HIV infection. Int J Dermatol 1996; 35: 475-479.
7. Talamonti M, Spallone G, Di Stefani A, Costanzo A, Chimenti S: Efalizumab. Expert Opin Drug Saf 2011; 10: 239-251.
8. Menon K, Van Voorhees AS, Bebo BF Jr, Gladman DD, Hsu S, Kalb RE, Lebwohl MG, Strober BE; National Psoriasis Foundation: Psoriasis in patients with HIV infection: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2010; 62: 291-299.
9. Patel RV, Weinberg JM: Psoriasis in the patient with human immunodeficiency virus. 2. Review of treatment. Cutis 2008; 82: 202- 210.
10. Buccheri L, Katchen BR, Karter AJ, Cohen SR: Acitretin therapy is effective for psoriasis associated with human immunodeficiency virus infection. Arch Dermatol 1997; 133: 711-715.
11. Mallon E, Bunker CB: HIV-associated psoriasis. AIDS Patient Care STDS 2000; 14: 239-246.
12. Masson C, Chennebault JM, Leclech C: Is HIV infection contraindication to the use of methotrexate in psoriatic arthritis? J Rheumatol 1995; 22: 2191.
13. Maurer TA, Zackheim HS, Tuffanelli L, Berger TG: The use of methotrexate for treatment of psoriasis in patients with HIV infection. J Am Acad Dermatol 1994; 31: 372-375.
14. Tourne L, Durez P, Van Vooren JP, Farber CM, Liesnard C, Heenen M, Parent D: Alleviation of HIV-associated psoriasis and psoriatic arthritis with cyclosporine. J Am Acad Dermatol 1997; 37: 501-502.
15. Jacobson SK, Calne RY, Wreghitt TG: Outcome of HIV infection in transplant patient on cyclosporin. Lancet 1991; 337: 794.
16. Allen BR: Use of cyclosporine for psoriasis in HIV positive patient. Lancet 1992; 339: 686.
17. Linardaki G, Katsarou O, Ioannidou P, Karafoulidou A, Boki K: Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection. J Rheumatol 2007; 34: 1353-1355.
18. Calabrese LH, Lederman MM, Spritzler J, Coombs RW, Fox L, Schock B, Yen-Lieberman B, Johnson R, Mildvan D, Parekh N, AIDS Clinical Trials Group 334 Investigators: Placebo-controlled trial of cyclosporin- A in HIV-1 disease: implications for solid organ transplantation J Acquir Immune Defic Syndr 2002; 29: 356-362.
19. Forman SB, Higginson R, Garrett AB: Psoriasis and psoriatic arthritis in a patient with HIV: response to mycophenolate mofetil treatment. J Drugs Dermatol 2008; 7: 972- 973.
20. Butera ST, Roberts BD, Folks TM: Ligand passing by the p75 tumour necrosis factor receptor enhances HIV-1 activation. Cytokine 1996; 8: 745-750.
21. Linardaki G, Katsarou O, Ioannidou P, Karafoulidou A, Boki K: Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection. J Rheumatol 2007; 34: 1353-1355.
22. Mikhail M, Weinberg JM, Smith BL: Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus. Arch Dermatol 2008; 144: 453-456.
23. Sellam J, Bouvard B, Masson C, Rousière M, Villoutreix C, Lacombe K, Khanine V, Chennebault JM, Leclech C, Audran M, Berenbaum F: Use of infliximab to treat psoriatic arthritis in HIV-positive patients. Joint Bone Spine 2007; 74: 197-200.
24. Gill H, Majithia V: Successful use of infliximab in the treatment of reactive arthritis: a case report and discussion. Clin Rheumatol 2008; 27: 121-123.
25. Duvic M, Rios A, Brewton GW: Remission of AIDS associated psoriasis with zidovudine. Lancet 1987;ii:627.
26. Ruzicka T, Fröschl M, Hohenleutner U, Holzmann H, Braun-Falco O: Treatment of HIV-induced retinoid-resistant psoriasis with zidovudine. Lancet 1987;ii: 1469-1470.
27. Feeney GF, Frazer I: AIDS-associated psoriasis responds to azidothymidine. Med J Aust 1988; 148: 155.
28. Kaplan MH, Sadick NS, Wieder J, Farber BF, Neidt GW: Antipsoriatic effects of zidovudine in human immunodeficiency virusassociated psoriasis. J Am Acad Dermatol 1989; 20: 76-82.
29. Díez F, del Hoyo M, Serrano S: Zidovudine treatment of psoriasis associated with acquired immunodeficiency syndrome. J Am Acad Dermatol 1990; 22: 146-147.
30. Fischer T, Schworer H, Vente C, Reich K, Ramadori G: Clinical improvement of HIVassociated psoriasis parallels a reduction of HIV viral load induced by effective antiretroviral therapy. AIDS 1999; 13: 628-629.
31. Vittorio Luigi De Socio G, Simonetti S, Stagni G: Clinical improvement of psoriasis in an AIDS patient effectively treated with combination antiretroviral therapy. Scand J Infect Dis 2006; 38: 74-75.
32. Duvic M, Crane MM, Conant M, Mahoney SE, Reveille JD, Lehrman SN: Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Arch Dermatol 1994; 130: 447-451.
33. Berthelot P, Guglielminotti C, Frésard A, Lucht F, Perrot JL: Dramatic cutaneous psoriasis improvement in a patient with the human immunodeficiency virus treated with 2 -, 3 - -dideoxy-3 - -thyacytidine [correction of 2 -, 3 - -dideoxycytidine] and ritonavir. Arch Dermatol 1997; 133: 531.
34. Bartke U, Venten I, Kreuter A, Gubbay S, Altmeyer P, Brockmeyer NH: Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab. Br J Dermatol 2004; 150: 784-786.